This message was sent to ##Email##
|
|
|
|
|
Outbreak News Today
A new report from the National Center for Health Statistics of the Centers for Disease Control and Prevention shows that rates of herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) decreased over a 16-year period. Prevalence of both HSV-1 (cold sores) and HSV-2 (genital herpes) decreased from 1999-2000 to 2015-2016.
READ MORE
University of Pittsburgh School of Medicine via Infection Control Today
A new blood test seems to perform as well as, if not better than, traditional blood cultures at detecting a type of fungal yeast infection that commonly strikes hospital patients, according to an analysis led by the University of Pittsburgh School of Medicine.
The T2Candida Panel is the first diagnostic test for candidemia — a type of bloodstream infection caused by Candida yeast — that has been cleared by the U.S. Food and Drug Administration and doesn't require culturing a blood sample from the patient to see what grows.
READ MORE
|
Promoted by
|
|
|
|
 |
The Washington Post
Four years after the United States pledged to help the world fight infectious-disease epidemics such as Ebola, the Centers for Disease Control and Prevention is dramatically downsizing its epidemic prevention activities in 39 out of 49 countries because money is running out, U.S. government officials said.
The CDC programs, part of a global health security initiative, train front-line workers in outbreak detection and work to strengthen laboratory and emergency response systems in countries where disease risks are greatest. The goal is to stop future outbreaks at their source.
READ MORE
|
|
Medical News Today
Researchers have discovered a mechanism through which toxic protein clusters develop in the brain in Parkinson's disease. It may be treatable with drugs approved for another disease.
READ MORE
 |
|
Even as traditional jobs are being replaced by automation, experts see an increase in demand for jobs in Life-Sciences and Data Analytics. If you're looking for a future-proof career that transforms lives, there's no better time than now. What if it could set you on a path of a six-figure income?
|
|
University of Zurich via Medical Xpress
Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.
READ MORE
Cleveland Clinic via ScienceDaily
Cleveland Clinic researchers have published findings in Nature Communications on a new stem cell pathway that allows a highly aggressive form of breast cancer — triple-negative breast cancer — to thrive.
Hormone therapy for breast cancer blocks cancer cells from interacting with hormones such as estrogen and progesterone, which fuel the cancer cells to grow and spread.
READ MORE
|
|
DARK Daily
Medical laboratories and anatomic pathology groups preparing for the transition from fee-for-service healthcare will want to keep a close eye on the Centers for Medicare & Medicaid Services (CMS). The federal agency's administrator plans to set a "new direction" for CMS as it shifts to value-based reimbursement models for Medicare services that could impact clinical laboratory revenues.
READ MORE
 |
|
The LIAISON® Treponema assay is your solution for automating syphilis testing. Improve sensitivity and specificity over RPR screening using our fully-automated LIAISON® XL platform. The LIAISON® Treponema assay detects both IgG and IgM antibody response to T. pallidum infections. Visit www.diasorin.com for more information.
|
|
Stony Brook University via Lab Manager
Cryptococcus neoformans is a fungal pathogen usually affecting immunocompromised patients, particularly AIDS and organ transplant patients, and is one that can be lethal. Current treatments against cryptococcosis are often not effective.
READ MORE
|
To find out how to feature your company in the ASCLS eNewsletter and other advertising opportunities, Contact James DeBois at 469-420-2618.
MORE
|
|
|
|
SeraSub® is a synthetic serum for use as a component in preparing standards and controls for in-vitro diagnostic tests. Learn more
|
|
|
|
Genetic Engineering & Biotechnology News
A member of a protein family that has previously been thought to play a tumor-suppressive role in breast cancer may in fact be key to the maintenance of self-renewing cancer stem cells that drive one of the most aggressive form of the disease. Studies by a Cleveland Clinic team found that the gap junction protein connexin 26 forms part of a signaling complex that drives cancer stem cell maintenance in triple-negative breast cancer via a pathway that isn't related to gap junction function.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
